Compare Adaptive Biotechnologies Corp (ADPT) vs Carnival Corp (CCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Carnival Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Carnival Corp trades at $27.96 (market cap $37.98B). The key difference: Carnival Corp is far larger — about 9.4× Adaptive Biotechnologies Corp's market cap, and Carnival Corp pays a 1.62% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | CCL | |
|---|---|---|
Market Cap | $4.04B | $37.98B |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $33.99 |
52-Week Low | $12.30 | $23.89 |
Enterprise Value | $4.10B | $61.91B |
Dividend Yield | — | 1.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Carnival Corp
Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.
Read more on CCL →
